HOME >> MEDICINE >> NEWS
Physicists study mad cow-type diseases

Using math and physics to investigate mad cow disease (bovine spongiform encephalopathy or BSE) and similar diseases caused by infectious proteins called prions is the aim of research by physicists Daniel Cox, Rajiv Singh and colleagues at UC Davis. The researchers are using mathematical models to study issues such as the incubation time, prion "strains" and treatment or detection strategies.

Diseases such as BSE in cattle, Creutzfeld-Jakob disease in humans and chronic wasting disease in deer are all apparently caused by prions, misfolded versions of a normal brain protein. Similar diseases have been found in other animals including cats, mink and rodents, and prion-type proteins have even been found in yeast.

Prions seem to cause disease by triggering normal versions of the same protein to spontaneously fold up the wrong way, creating growing mats and tangles.

The UC Davis researchers have developed mathematical models to simulate this process. The models reproduce how prions collect around an original "seed" prion, and how these clumps subsequently break up and spread around the brain and nervous system.

Predictions from the models compare well with the course of actual disease in both small and large animals, Cox said.

Cox and colleagues are now using the model system to investigate the minimal requirements for prions to cause disease; how "strains" of prions can exist and what effect they have; and potential treatment strategies.


'"/>

Contact: Andy Fell
ahfell@ucdavis.edu
530-752-4533
University of California - Davis
23-Jan-2004


Page: 1

Related medicine news :

1. Physicists find patterns within seemingly random events of physiological systems
2. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
3. UMaine study looks at infants and chronic nighttime crying
4. Chronic pain treatments more effective when taken together, new study shows
5. UNC study: Most N.C. family practitioners engage in unrecognized community service
6. New study in Nature demonstrates protection against cell death during heart attack
7. UCSF study offers insight into human circadian rhythms
8. International breast cancer prevention study launches in the United States and Canada
9. UW study shows blacks and Latinos are more satisfied with physicians of the same race
10. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
11. Advertising by academic medical centers may risk eroding public trust, says study

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Physicists study mad cow type diseases

(Date:10/31/2014)... effort by the National Institutes of Health will ... to reframe mental health research, from diagnosis to ... recently established by the National Institute of Mental ... development of the institute,s RDoC initiative. , ... accelerate the pace of research that translates basic ...
(Date:10/31/2014)... News) -- A comparison of two of the most ... gastric bypass helped patients shed more excess pounds than ... short-term complications and long-term hospitalizations. Gastric-bypass surgery makes ... your body does not absorb all the calories from ... Health. Gastric banding is a type of weight-loss procedure ...
(Date:10/31/2014)... Steven Reinberg HealthDay Reporter THURSDAY, ... increase slightly the risk of broken bones and injured joints, a ... found that among 7 percent of people who had an eczema ... joint injury and 0.6 percent had an injury that caused a ... with the skin condition had more than double the risk of ...
(Date:10/30/2014)... one day provide new treatments for injuries and damage ... , Cartilage, for example, is a hard material that ... work smoothly. UC Davis biomedical engineers, exploring ways to ... outside the body, report new developments this week in ... Sciences . , "The problem with engineered tissue is ...
(Date:10/30/2014)... , A mathematical model developed by NIH grantees predicts ... to prevent HIV infection via vaginal sex, whereas just ... infection via anal sex. This finding helps explain why ... PrEP, in women failed to show efficacy. Participants in ... of Truvada and tenofovir (another antiretroviral) for HIV prevention ...
Breaking Medicine News(10 mins):Health News:NIMH creates new unit to support its research domain criteria initiative 2Health News:Study Compares 2 Common Weight-Loss Surgeries 2Health News:Study Compares 2 Common Weight-Loss Surgeries 3Health News:Eczema Tied to Bone Fracture Risk in Study 2Health News:Making lab-grown tissues stronger 2Health News:Model by NIH grantees explains why HIV prevention dosing differs by sex 2
(Date:10/31/2014)... LONDON , October 31, 2014 ... (NYSE: MDT ), Abbott Laboratories (NYSE: ... Inc. (NYSE: RMD ), and Covidien PLC (NYSE: ... at: http://investor-edge.com/register . The US markets on ... the Dow Jones Industrial Average finished at 17,195.42, up 1.30% ...
(Date:10/31/2014)... Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, ... 30, 2014. Brian M. Culley, the ... productive for Mast. Consistent with prior guidance, our 388-patient pivotal ... is on track to complete enrollment by the end ... in the U.S. and more than ten study sites ...
(Date:10/31/2014)... , October 31, 2014 ... a clinical-stage pharmaceutical company focused on the development ... company will host a conference call to discuss ... trial of ORMD-0801, the company,s proprietary oral insulin ... November 3, 2014 at 10:00 a.m. Eastern time. ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 2Mast Therapeutics Reports Third Quarter 2014 Financial Results 3Mast Therapeutics Reports Third Quarter 2014 Financial Results 4Mast Therapeutics Reports Third Quarter 2014 Financial Results 5Mast Therapeutics Reports Third Quarter 2014 Financial Results 6Mast Therapeutics Reports Third Quarter 2014 Financial Results 7Mast Therapeutics Reports Third Quarter 2014 Financial Results 8Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3
Cached News: